These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8216835)
21. Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 A resolution. Booy FP; Roden RB; Greenstone HL; Schiller JT; Trus BL J Mol Biol; 1998 Aug; 281(1):95-106. PubMed ID: 9680478 [TBL] [Abstract][Full Text] [Related]
22. Epitopes on 14S subunits, natural empty capsids and virions of bovine enteroviruses. Zhang AQ; Burgess GW Virus Res; 1990 Jul; 16(3):235-46. PubMed ID: 1697440 [TBL] [Abstract][Full Text] [Related]
23. Type-specific L1 virus-like particle-mediated protection of horses from experimental bovine papillomavirus 1-induced pseudo-sarcoid formation is long-lasting. Harnacker J; Hainisch EK; Shafti-Keramat S; Kirnbauer R; Brandt S J Gen Virol; 2017 Jun; 98(6):1329-1333. PubMed ID: 28635592 [TBL] [Abstract][Full Text] [Related]
24. Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies. Jin XW; Cowsert LM; Pilacinski WP; Jenson AB J Gen Virol; 1989 May; 70 ( Pt 5)():1133-40. PubMed ID: 2471804 [TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies against different epitopes of a 40 Kd capsid protein of infectious bursal disease viruses. Lee LH Proc Natl Sci Counc Repub China B; 1990 Apr; 14(2):75-84. PubMed ID: 1701058 [TBL] [Abstract][Full Text] [Related]
26. Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides. Lim PS; Jenson AB; Cowsert L; Nakai Y; Lim LY; Jin XW; Sundberg JP J Infect Dis; 1990 Dec; 162(6):1263-9. PubMed ID: 1700026 [TBL] [Abstract][Full Text] [Related]
27. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405 [TBL] [Abstract][Full Text] [Related]
28. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. Gahéry-Ségard H; Farace F; Godfrin D; Gaston J; Lengagne R; Tursz T; Boulanger P; Guillet JG J Virol; 1998 Mar; 72(3):2388-97. PubMed ID: 9499099 [TBL] [Abstract][Full Text] [Related]
29. Cell surface-binding motifs of L2 that facilitate papillomavirus infection. Yang R; Day PM; Yutzy WH; Lin KY; Hung CF; Roden RB J Virol; 2003 Mar; 77(6):3531-41. PubMed ID: 12610128 [TBL] [Abstract][Full Text] [Related]
30. Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the 'common antigen' region. Strike DG; Bonnez W; Rose RC; Reichman RC J Gen Virol; 1989 Mar; 70 ( Pt 3)():543-55. PubMed ID: 2471790 [TBL] [Abstract][Full Text] [Related]
31. [Immunogenicity study of HPV 6b virus-like particles]. Liu Y; Liu X; Frazer IH Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):587-9. PubMed ID: 12133476 [TBL] [Abstract][Full Text] [Related]
32. Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies. Carpentier GS; Fleury MJ; Touzé A; Sadeyen JR; Tourne S; Sizaret PY; Coursaget P J Med Virol; 2005 Dec; 77(4):558-65. PubMed ID: 16254978 [TBL] [Abstract][Full Text] [Related]
34. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Christensen ND; Dillner J; Eklund C; Carter JJ; Wipf GC; Reed CA; Cladel NM; Galloway DA Virology; 1996 Sep; 223(1):174-84. PubMed ID: 8806551 [TBL] [Abstract][Full Text] [Related]
35. Route of administration of chimeric BPV1 VLP determines the character of the induced immune responses. Liu XS; Liu WJ; Zhao KN; Liu YH; Leggatt G; Frazer IH Immunol Cell Biol; 2002 Feb; 80(1):21-9. PubMed ID: 11869359 [TBL] [Abstract][Full Text] [Related]
36. Bovine papillomavirus type 1 monoclonal antibodies. Gorra JB; Lancaster WD; Kurman RJ; Jenson AB J Natl Cancer Inst; 1985 Jul; 75(1):121-5. PubMed ID: 2989600 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus. Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367 [TBL] [Abstract][Full Text] [Related]
38. Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2. Pastrana DV; Gambhira R; Buck CB; Pang YY; Thompson CD; Culp TD; Christensen ND; Lowy DR; Schiller JT; Roden RB Virology; 2005 Jul; 337(2):365-72. PubMed ID: 15885736 [TBL] [Abstract][Full Text] [Related]
39. Antibody-mediated neutralization in vivo of infectious papillomaviruses. Christensen ND; Kreider JW J Virol; 1990 Jul; 64(7):3151-6. PubMed ID: 1693698 [TBL] [Abstract][Full Text] [Related]
40. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Pastrana DV; Buck CB; Pang YY; Thompson CD; Castle PE; FitzGerald PC; Krüger Kjaer S; Lowy DR; Schiller JT Virology; 2004 Apr; 321(2):205-16. PubMed ID: 15051381 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]